Evidence map›Paper›PMID 37414018›Full record

ArticleThe Lancet. Oncology2023

Adjuvant chemotherapy for locally advanced cervical cancer - Authors' reply.

Linda R Mileshkin, Kailash Narayan, David K Gaffney, Elizabeth H Barnes, Yeh Chen Lee, Bradley J Monk, Martin R Stockler

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Linda R MileshkinDepartment of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne 3000, VIC, Australia. Electronic address: linda.mileshkin@petermac.org.
Kailash NarayanUniversity of Melbourne, Melbourne, VIC, Australia.
David K GaffneyHuntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA.
Elizabeth H BarnesNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
Yeh Chen LeeNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
Bradley J MonkHonorHealth Research Institute, University of Arizona, Creighton University, Phoenix, AZ, USA.
Martin R StocklerNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Uterine Cervical NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCisplatinDisease-Free SurvivalFemaleHumansNeoadjuvant TherapyNeoplasm StagingCisplatin

Identifiers

PMID37414018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.